Equities

Sumitomo Dainippon Pharma Co Ltd

Sumitomo Dainippon Pharma Co Ltd

Actions
Health CarePharmaceuticals & Biotechnology
  • Price (JPY)2,229.00
  • Today's Change-53.00 / -2.32%
  • Shares traded364.10k
  • 1 Year change+61.99%
  • Beta0.8224
Data delayed at least 20 minutes, as of Jul 27 2021 05:40 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Key statistics

As of last trade Sumitomo Dainippon Pharma Co Ltd (4506:TYO) traded at 2,229.00, -5.67% below its 52-week high of 2,363.00, set on Jun 10, 2021.
52-week range
Today
1,180.00Oct 28 20202,363.00Jun 10 2021
Markit short selling activity
Low
Med
High
Open2,282.00
High2,286.00
Low2,218.00
Bid2,228.00
Offer2,230.00
Previous close2,282.00
Average volume579.46k
Shares outstanding397.90m
Free float160.12m
P/E (TTM)15.93
Market cap896.87bn JPY
EPS (TTM)141.50
JPY
Annual div (ADY)28.00
JPY
Annual div yield (ADY)1.24%
Div ex-dateMar 30 2021
Div pay-dateJun 25 2021
Next div ex-dateSep 29 2021
Next div pay-date--
Data delayed at least 20 minutes, as of Jul 27 2021 05:40 BST.
More ▼
Refinitiv, an LSEG business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.